Research advances in renal replacement therapy for hepatorenal syndrome
10.3969/j.issn.1001-5256.2016.03.046
- VernacularTitle:肾脏替代疗法治疗肝肾综合征的研究进展
- Author:
Li CHEN
1
;
Yong MEI
;
Yibin YANG
Author Information
1. Department of Nephropathy, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, China
- Publication Type:Research Article
- Keywords:
liver cirrhosis;
hepatorenal syndrome;
renal replacement therapy;
review
- From:
Journal of Clinical Hepatology
2016;32(3):605-608
- CountryChina
- Language:Chinese
-
Abstract:
Hepatorenal syndrome (HRS) is a serious complication of the end-stage liver disease. The overall treatment outcome of HRS is not satisfactory, with a short survival time and a poor prognosis. Currently, renal replacement therapy is one of the main non-transplantation therapeutic methods, but its clinical effect remains controversial. This review summarizes the research on HRS and advances in the clinical effect of renal replacement therapy for HRS, and points out that renal replacement therapy is not suitable as the conventional therapy for HRS, but it can be applied as the pre-transplantation transitional treatment for patients with a plan for liver transplantation, as well as the short-term treatment for non-transplantation patients who do not respond to vasoconstrictors.
